Allscripts Healthcare Solutions, Inc.【MDRX】 業績推移・財務諸表

(単位:千ドル) 1Q11 2Q11 3Q11 1Q12 2Q12 3Q12 1Q13 2Q13 3Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22
売上高 335,308 356,831 368,763 364,712 369,956 360,694 347,066 344,827 330,191 340,285 351,296 345,389 340,903 334,552 351,718 354,476 345,647 345,558 386,521 392,384 425,436 413,475 426,091 449,442 517,334 513,926 525,577 522,279 442,346 432,049 444,460 444,184 450,984 416,713 406,223 402,030 386,414 368,352 373,714 369,272 391,699 142,672 150,898 151,922 156,212
売上成長率(%) - - - -
売上原価 175,458 189,036 201,763 209,035 212,466 203,658 212,638 208,545 204,644 202,099 211,308 213,933 204,549 204,762 208,094 201,128 191,844 193,660 219,837 226,225 239,138 234,823 238,600 247,523 303,235 292,951 312,914 303,908 254,187 257,954 260,338 268,882 270,923 259,752 241,739 240,433 225,391 218,307 221,961 220,498 - 69,191 71,416 68,486 69,361
売上総利益 159,850 167,795 167,000 155,677 157,490 157,036 134,428 136,282 125,547 138,186 139,988 131,456 136,354 129,790 143,624 153,348 153,803 151,898 166,684 166,159 186,298 178,652 187,491 201,919 214,099 220,975 212,663 218,371 188,159 174,095 184,122 175,302 180,061 156,961 164,484 161,597 161,023 150,045 151,753 148,774 - 73,481 79,482 83,436 86,851
売上総利益率(%) -
研究開発費 22,004 24,764 26,032 36,122 38,240 37,802 50,978 51,822 49,400 52,305 53,016 45,962 41,538 46,727 44,367 47,702 45,995 47,037 47,891 45,142 47,836 49,232 46,459 51,057 73,471 69,977 80,342 69,747 66,096 64,310 63,414 63,873 62,912 62,155 48,282 48,476 54,287 49,173 51,219 45,540 - 23,420 22,750 23,681 26,981
販売管理費 104,148 101,532 94,120 97,317 92,291 90,412 104,232 104,402 104,506 89,946 86,663 97,034 85,038 82,029 86,749 91,043 79,354 84,153 94,802 98,778 115,132 110,845 112,037 117,352 146,037 143,070 149,081 133,214 99,992 100,245 105,542 101,152 112,835 97,288 114,620 97,231 93,777 81,708 79,090 78,794 - 41,318 59,847 32,518 43,651
営業利益 24,471 32,077 37,426 12,983 17,704 9,184 -28,283 -28,321 -43,452 -11,911 -9,093 -18,840 656 -5,695 5,591 8,869 23,118 11,896 18,574 16,874 12,427 11,263 21,104 25,373 -15,823 -4,320 -58,797 2,410 -26,443 2,645 4,743 3,182 -35,026 -9,200 -4,746 9,379 -68,078 13,340 10,375 12,104 - 6,572 -5,356 25,001 -9,462
営業利益率 (%) -
経常(税引前)利益 16,948 27,382 34,105 9,521 13,496 -10,379 -24,789 -37,602 -51,173 -19,176 -16,093 -26,211 -6,637 -11,065 -1,744 -1,441 14,820 2,690 -2,639 -2,499 -12,336 -8,393 -144,018 -17,700 -39,507 -35,844 78,639 -27,635 -40,044 -6,045 -150,457 -6,490 -43,524 -20,700 -700 1,500 -74,750 11,300 24,100 21,300 - 4,050 -5,317 24,793 -8,928
経常(税引前)利益率(%) 5.05 7.67 9.25 2.61 3.65 -2.88 -7.14 -10.9 -15.5 -5.64 -4.58 -7.59 -1.95 -3.31 -0.5 -0.41 4.29 0.78 -0.68 -0.64 -2.9 -2.03 -33.8 -3.94 -7.64 -6.97 14.96 -5.29 -9.05 -1.4 -33.85 -1.46 -9.65 -4.97 -0.17 0.37 -19.34 3.07 6.45 5.77 - 2.84 -3.52 16.32 -5.72
法人税等合計 4,335 11,506 13,121 3,708 5,515 -19,754 -13,197 -14,726 -2,233 1,566 1,677 -448 -4,459 -981 1,472 3,692 -1,557 563 -503 -2,656 -15,218 172 -1,007 -238 -49,694 -2,914 3,683 -3,789 -5,449 1,932 -527 -765 -24,554 -347 6,873 931 -10,051 2,663 2,192 5,099 - -14,421 -8,579 13,868 17,952
実効税率(%) -
純利益 12,613 15,876 20,984 5,813 7,981 9,375 -11,592 -22,876 -48,940 -20,742 -17,770 -25,763 -2,178 -10,084 -3,216 -5,133 16,377 2,127 -2,136 157 2,882 -8,565 -143,011 -17,462 14,863 -28,515 74,272 -23,846 385,896 -7,977 -149,930 -5,725 -18,970 -20,354 -7,605 542 727,824 9,057 21,926 16,180 - 22,857 -64,026 14,528 -26,555
純利益率(%) -
一株あたり利益 0.07 0.08 - - - - - - - - - - - - - - - 0.01 -0.05 -0.06 - -0.11 -0.85 -0.16 0.03 -0.22 0.36 -0.2 2.17 -0.04 -0.9 -0.03 -0.12 -0.13 -0.05 0 4.82 0.06 0.16 0.13 - 0.2 -0.56 0.13 -0.25
希薄化後一株あたり利益 0.06 0.08 - - - - - - - - - - - - - - - 0.01 -0.05 -0.06 - -0.11 -0.85 -0.16 0.03 -0.22 0.36 -0.2 2.14 -0.04 -0.9 -0.03 -0.12 -0.13 -0.05 0 4.82 0.06 0.15 0.12 - 0.17 -0.54 0.12 -0.25
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -